Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Deciphera Pharmaceuticals Inc (DCPH) Stock Forecast 2025 - AI Price Prediction & Analysis

Deciphera Pharmaceuticals Inc (DCPH) AI Stock Price Forecast & Investment Analysis

Deciphera Pharmaceuticals Inc Stock Price Chart and Technical Analysis

Loading Deciphera Pharmaceuticals Inc interactive price chart and technical analysis...

Deciphera Pharmaceuticals Inc (DCPH) - Comprehensive Stock Analysis & Investment Research

Deep dive into Deciphera Pharmaceuticals Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Deciphera Pharmaceuticals Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Deciphera Pharmaceuticals Inc:

Deciphera Pharmaceuticals Inc (Stock Symbol: DCPH) .

The organization employs approximately 350 professionals worldwide and operates under the strategic leadership of CEO Steven Hoerter.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Deciphera Pharmaceuticals Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Deciphera Pharmaceuticals Inc: With $100M in annual revenue and -285.0% net margin, the company demonstrates developing profitability.

Annual Revenue: $100 million generating a -285.0% net profit margin .

Market Capitalization: $803 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -73.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Deciphera Pharmaceuticals Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Deciphera Pharmaceuticals Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Deciphera Pharmaceuticals Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Deciphera Pharmaceuticals Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Deciphera Pharmaceuticals Inc: Market positioning analysis based on available financial and operational metrics.

Deciphera Pharmaceuticals Inc strategically competes in the highly dynamic sector, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 96.9% gross margin, indicating strong pricing power and operational efficiency.

Deciphera Pharmaceuticals Inc (DCPH) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Deciphera Pharmaceuticals Inc stock analysis.

Loading Deciphera Pharmaceuticals Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Deciphera Pharmaceuticals Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Deciphera Pharmaceuticals Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Deciphera Pharmaceuticals Inc: With a P/E ratio of -2.82, the market sees the stock as potentially undervalued.

P/E Ratio -2.82x
P/B Ratio 3.38x
Market Cap $803M
EPS $-4.90
Book Value/Share $4.10
Revenue/Share $1.72
FCF/Share $-4.66
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Deciphera Pharmaceuticals Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Deciphera Pharmaceuticals Inc: An ROE of -73.7% indicates room for improvement in shareholder value creation.

ROE -73.7%
ROA -58.2%
ROIC -68.3%
Gross Margin 96.9%
Operating Margin -284.9%
Net Margin -285.0%
EBT Margin -285.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Deciphera Pharmaceuticals Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Deciphera Pharmaceuticals Inc: A current ratio of 3.69 indicates strong liquidity.

Current Ratio 3.69x
Quick Ratio 3.23x
D/E Ratio 0.10x
Financial Leverage 1.42x
Interest Coverage -528.3x
Working Capital $514M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Deciphera Pharmaceuticals Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Deciphera Pharmaceuticals Inc: Free cash flow of $-230M indicates cash challenges that need attention.

Operating Cash Flow $-224M
Free Cash Flow $-230M
Capital Spending $-6M
FCF/Sales -229.3%
CapEx/Sales 6.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Deciphera Pharmaceuticals Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Deciphera Pharmaceuticals Inc: An asset turnover of 0.20x suggests room for improvement in asset utilization.

Asset Turnover 0.20x
Receivables Turnover 4.5x
Inventory Turnover 0.2x
Fixed Assets Turnover 2.3x
Days Sales Outstanding 82 days
Days Inventory 1577 days
Payables Period 1753 days
Cash Conversion Cycle -95 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Deciphera Pharmaceuticals Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Deciphera Pharmaceuticals Inc: With annual revenue of $100M, Deciphera Pharmaceuticals Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $100M
Operating Income $-285M
Net Income $-286M
R&D Expense $248M
SG&A Expense $134M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 83%
Cash & Short-term Investments 67%
Total Liabilities 30%
Short-term Debt 0%
Accounts Receivable 6%
Inventory 5%
Dividend & Shareholder Information
Shares Outstanding 58M

Latest Deciphera Pharmaceuticals Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Deciphera Pharmaceuticals Inc (DCPH) stock price and investment outlook.

Deciphera Pharmaceuticals Inc Competitors & Peer Analysis -

Comparative analysis of Deciphera Pharmaceuticals Inc against industry peers and competitors in the sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Deciphera Pharmaceuticals Inc Stock Forecast

How accurate are Deciphera Pharmaceuticals Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for DCPH predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Deciphera Pharmaceuticals Inc stock price forecasts?

Our analysis considers Deciphera Pharmaceuticals Inc's financial metrics, sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Deciphera Pharmaceuticals Inc a good investment in 2025?

Based on our AI analysis, Deciphera Pharmaceuticals Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Deciphera Pharmaceuticals Inc forecasts updated?

Deciphera Pharmaceuticals Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Deciphera Pharmaceuticals Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Deciphera Pharmaceuticals Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...